
A new study has shed light on how a class of diabetes drugs may protect the kidneys — not just by lowering blood sugar, but by triggering a molecular shift that dampens inflammation, according to the study published in The Journal of Clinical Investigation.

Northwestern Medicine scientists have discovered that a subset of laboratory-modified T-cells can promote the repair of lung tissue damaged by viral pneumonia, according to a recent study published in The Journal of Clinical Investigation.

In a pair of studies, investigators from the lab of Huiping Liu, MD, PhD, have uncovered how specific cellular interactions in the bloodstream may be fueling the spread of breast cancer.

Northwestern scientists have discovered that the organization of a cell’s genetic material dictates cancer’s ability to adapt, according to a recent study published in the Proceedings of the National Academy of Sciences.

A new wireless and wearable device developed by Northwestern Medicine scientists measures specific biomarkers in a person’s sweat and has the potential to improve clinical decision-making for cystic fibrosis, as detailed in a recent study published in the Proceedings of the National Academy of Sciences.

A novel drug may significantly improve outcomes for a subset of patients with high blood pressure, according to findings published in The New England Journal of Medicine.

Investigators led by Navdeep Chandel, PhD, have discovered how mitochondrial metabolism supports T-cell proliferation and also prevents T-cell exhaustion in cancer and chronic infection, according to a recent study published in Nature Immunology.

“Dancing molecules,” a promising new treatment for acute spinal cord injuries developed at Northwestern University, has received Orphan Drug Designation from the U.S. Food and Drug Administration.

The use of an automated insulin delivery system in patients with type 2 diabetes resulted in a greater reduction in glucose levels compared to usual care plus continuous glucose monitoring, according to a recent clinical trial published in the New England Journal of Medicine.

Measuring standard cardiac biomarkers did not predict whether patients with asymptomatic severe aortic stenosis would benefit from nonsurgical aortic valve replacement, according to a recent study published in Circulation.